Table 2.
Demographic characteristics at baseline of ASCT potentially eligible patients aged at most 65 who achieved CR after induction
| All patients N = 82 | ASCT patients N = 13 | |
|---|---|---|
| Age, median (range) | 39.5 (16.0–64.0) | 43 (19–63) |
| Male, N (%) | 49 (59.8) | 8 (62) |
| ECOG, N (%) | ||
| 0–1 | 61 (81.3) | 7 (54) |
| 2 | 4 (5.3) | 1 (8) |
| ≥ 3 | 10 (13.3) | 3 (23) |
| Missing | 7 | 2 |
| ALK positive, N (%) | 49 (60.5) | 0 (0) |
| Missing | 1 | 0 |
| B symptoms, N (%) | 39 (52.0) | 7 (54) |
| Missing | 7 | 3 (23) |
| BM involvement, N (%) | 7 (11.1) | 5 (38) |
| Missing | 19 | 4 |
| Stagea, N (%) | ||
| I | 11 (13.9) | 2 (15) |
| II | 26 (32.9) | 3 (23) |
| III | 11 (13.9) | 1 (8) |
| IV | 31 (39.2) | 6 (46) |
| Missing | 3 | 1 |
| ≥ 2 extranodal sites, N (%) | 22 (27.8) | 5 (38) |
| Missing | 3 | 1 |
| High LDH, N (%) | 35 (47.9) | 8 (62) |
| Missing | 9 | 1 |
| IPI score, grouped, N (%)b | ||
| Low: 0–2 | 60 (75.9) | 7 (54) |
| High: 3+ | 15 (22.7) | 4 (31) |
| Missing | 16 | 2 |
| PIT score, grouped, N (%)b | ||
| Low: 0–1 | 51 (77.3) | 5 (54) |
| High: 2+ | 15 (22.7) | 2 (15) |
| Missing | 16 | 6 |
aStage based on CT and when available PET/CT
bMissing scores grouped if definitely low or high regardless of missing values